Amyloid β-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by...

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Microglia activation and IL-1β release are crucial in neuroinflammation, particularly in response to amyloid-beta (Aβ).
• The P2X7 receptor (P2X7R) plays a key role in Aβ-stimulated microglia responses.
• Nimodipine, a dihydropyridine, has shown inhibitory effects on Aβ-dependent stimulation at an intracellular site.

Purpose of the Study:

• To investigate the effect of nimodipine on Aβ-dependent NLRP3 inflammasome expression and function in microglia.
• To assess the impact of nimodipine on mitochondrial energy metabolism in the context of Aβ exposure.
• To elucidate the role of P2X7R in Aβ-induced cellular changes and the inhibitory mechanism of nimodipine.

Main Methods:

• Utilized the N13 microglia cell line and primary microglia from wild-type and P2rx7-deleted mice.
• Assessed Aβ-dependent NFκB activation, NLRP3 inflammasome expression and function, and mitochondrial toxicity.
• Evaluated the inhibitory effects of nimodipine on these Aβ-induced cellular processes.

Main Results:

• Amyloid-beta (Aβ) triggers P2X7R-dependent NFκB activation, NLRP3 inflammasome activation, and mitochondrial toxicity in microglia.
• These Aβ-induced detrimental effects are completely inhibited by nimodipine.
• Nimodipine effectively blocks cell damage induced by both monomeric and oligomeric Aβ species.

Conclusions:

• Nimodipine is a potent inhibitor of Aβ-induced microglia activation and cell damage.
• Mitochondria are identified as a critical target for nimodipine's protective effects.
• The P2X7 receptor is essential for mediating Aβ-induced cellular dysfunction, with nimodipine acting as a key inhibitor.